Groups announce progress against neglected diseases

Although many Americans have never heard of diseases such as sleeping sickness or river blindness, they are among the most common infections of the world’s poor. Neglected tropical diseases (NTDs) debilitate or kill more than one billion people each year in the developing world. Fortunately, several groups have recently announced progress in developing new NTD therapies.

Read more

Conference highlights private sector's role in global health

Over the past 30 years, technology has revolutionized the health care available to patients in the developed world, and the private sector has played a huge role in this health revolution. In the developing world, however, millions die each year because they do not have the right vaccines, drugs, diagnostics, and other tools for neglected diseases. Last month, the Partnering for Global Health Forum 2011 brought together leaders in the private sector and other key arenas to examine challenges and opportunities in global health research and development.

Read more 

Agency spotlight: DoD

A new report from the Center for Strategic and International Studies has found that the Department of Defense (DoD) overseas medical research laboratories fundamentally contribute to US military readiness while also helping to develop lifesaving global health products.

Read more

Photos (top to bottom): Aurelio Ayala III, Scott Areman, Carib Nelson 

July 2011

UPCOMING EVENTS

July 17-20, 2011
6th Annual International AIDS Society (IAS) Conference on Pathogenesis, Treatment, and Prevention

July 26, 2011
Making AIDS History: Ending the Epidemic

July 27-28, 2011
Saving lives at birth: A grand challenge for development

NEW AND NOTEWORTHY

Two studies find that oral antiretrovirals can reduce the risk of HIV

NIH director lays out new translational science center

Partnership advances sleeping sickness drug candidate

CDC identifies top global public health achievements

Aid innovation is helping to develop new treatments and save lives

New partnerships are leading to a renaissance in global health research, blog post says

Global drug R&D spending fell in 2010

WHO prequalifies typhoid vaccine

Patent Pool announces first-ever agreement with pharmaceutical company

Funding increase for malaria research leads to largest pipeline of new tools

Researchers develop non-invasive dengue test


MEMBER FOCUS

The GHTC and members PATH, Research!America, and BIO Ventures for Global Health hosted a briefing in partnership with US Representatives Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) to highlight how public-private partnerships are catalyzing innovative, affordable solutions that save lives worldwide.

Read more about the event

Read an opinion piece by Congressman Sires

Received this as a forward? Click here to sign up for future issues.

If you wish to unsubscribe, please click here to send us a message. We will remove your name from our mailing list as soon as possible.

The Global Health Technologies Coalition (GHTC) is a group of almost 40 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostic tests, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and streamlined regulatory systems. Learn more at www.ghtcoalition.org.

To see a list of GHTC members, click here.

We respect the privacy of our online relationships. our mailing lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law.